1991
National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.
Rosenberg PS, Gail MH, Schrager LK, Vermund SH, Creagh-Kirk T, Andrews EB, Winkelstein W, Marmor M, Des Jarlais DC, Biggar RJ. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 392-401. PMID: 2007974.Peer-Reviewed Original ResearchConceptsIntravenous drug usersAIDS incidence trendsIncidence trendsDrug usersHeterosexual contactSevere immunodeficiencyHeterosexual intravenous drug usersHuman immunodeficiency virus (HIV) infectionFavorable trendTransmission groupImmunodeficiency virus infectionIncidence of AIDSCases of AIDSZidovudine therapyTransfusion recipientsVirus infectionNumber of casesZidovudineNew York CityEarly cessationTherapyAIDSMenGay menSan Francisco
1990
Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus.
Feingold AR, Vermund SH, Burk RD, Kelley KF, Schrager LK, Schreiber K, Munk G, Friedland GH, Klein RS. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1990, 3: 896-903. PMID: 2166784.Peer-Reviewed Original ResearchConceptsSquamous intraepithelial lesionsHIV-positive womenCervical cytologic abnormalitiesCytologic abnormalitiesCervical cytologyAsymptomatic HIV-positive womenHuman immunodeficiency virus (HIV) infectionHIV-negative womenHuman papillomavirus infectionImmunodeficiency virus infectionSymptomatic HIV infectionIntravenous drug useHuman immunodeficiency virusIntravenous drug usersFemale genital tractWestern blot confirmationCervicovaginal lavageHPV determinationSeronegative womenHPV infectionPapillomavirus infectionCytological lesionsHIV infectionIntraepithelial lesionsImmunodeficiency virus
1989
ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988
DRUCKER E, VERMUND S. ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988. American Journal Of Epidemiology 1989, 130: 133-142. PMID: 2787104, DOI: 10.1093/oxfordjournals.aje.a115304.Peer-Reviewed Original ResearchConceptsIntravenous drug usersDrug usersAIDS casesIntravenous drug-using populationHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionIntravenous drug useHuman immunodeficiency virusAge group 25HIV prevalence estimatesAge 13 yearsDrug-using populationsHIV seroprevalenceImmunodeficiency syndromeAIDS patientsImmunodeficiency virusRisk factorsVirus infectionUse populationGroup 25Seroprevalence rangesPopulation prevalencePrevalence estimatesDrug useHigh rateA Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
Selwyn P, Hartel D, Lewis V, Schoenbaum E, Vermund S, Klein R, Walker A, Friedland G. A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection. New England Journal Of Medicine 1989, 320: 545-550. PMID: 2915665, DOI: 10.1056/nejm198903023200901.Peer-Reviewed Original ResearchConceptsHIV-seropositive subjectsIntravenous drug usersPositive PPD testHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionActive tuberculosisPPD testDrug usersSeronegative subjectsSeropositive subjectsTuberculous infectionSkin testingVirus infectionHIV-seronegative intravenous drug usersHIV-seronegative subjectsLatent tuberculous infectionRisk of tuberculosisTuberculin skin testingCases of tuberculosisMethadone maintenance programHIV antibodiesHIV-seropositiveHIV infectionProspective studyProtein derivative (PPD) tuberculin